Siderails as a Measure of Physical Restraint. GERBAR Trial

计划入组 355 人 · 首次发布于 2021 年 4 月 27 日

Becoming HIV-Exposed, Uninfected Children Born to HIV-Positive Mothers Followed at Bichat Claude Bernard Hospital

计划入组 172 人 · 首次发布于 2024 年 10 月 30 日

Prospective Analysis of "Genotype-phenotype" Correlations Observed in a Large Cohort of Patients With Hereditary Retinal Dystrophies - GEPHIRD

计划入组 103 人 · 首次发布于 2018 年 9 月 7 日

Verard

105A5 (Eberhard Karls Universität Tübingen)

Metavac(Université Claude Bernard Lyon 1)

Andersson, Gerhard

Sweden

Gerhard Treiber

Germany

Gerhard Rogler

Switzerland

Augustine Therapeutics Secures €78 Million to Advance HDAC6 Inhibitor for Charcot-Marie-Tooth Disease

Augustine Therapeutics Raises €78 Million Series A to Advance Novel HDAC6 Inhibitor for Charcot-Marie-Tooth Disease

Augustine Therapeutics Appoints Rie Schultz Hansen as CSO, Establishes Copenhagen Subsidiary to Advance HDAC6 Inhibitor Pipeline